IP Library Granted Patent US 7,867,500
Granted Patent B2
US 7,867,500 · App. 11/510,859 · Granted Jan 11, 2011

Cofactor that modulates steroid receptor activities

Assignee: The United States of America as represented by the Department of Health and Human Services
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,867,500
App. No.
11/510,859
Granted
Jan 11, 2011
Kind
B2
Abstract

The invention provides a new glucocorticoid receptor coactivator named STAMP (Steroid receptor coactivator-1 and Transcription intermediary factor-2 Associated Modulatory Protein) that can modulate transcription of glucocorticoid-, progesterone-, mineralocorticoid- and androgen-responsive genes. The invention also provides antibodies that can bind STAMP and modulate its activity. In addition, the invention provides antisense, ribozyme and siRNA STAMP nucleic acids that can modulate the expression of STAMP. Also provided are compositions and methods for modulating glucocorticoid-responsive gene expression and for treating a variety of diseases and conditions.

Claims (3)

1. A method of modulating the activity of a steroid or nuclear receptor selected from the group consisting of a glucocorticoid receptor, a progesterone receptor, an androgen receptor and a mineralocorticoid receptor, in a mammal comprising administering to the mammal a composition comprising a carrier and an effective amount of a Steroid receptor coactivator-1 and Transcription intermediary factor 2 Associated Modulatory Protein (STAMP) polypeptide selected from the group consisting of SEQ ID NO: 1, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:70 and a combination thereof.

2. The method of claim 1 , wherein the receptor is a glucocorticoid receptor.

3. The method of claim 1 , wherein the composition also comprises a ligand, coactivator, agonist, partial agonist or antagonist for the receptor.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 22, 2006
From: SIMONS, S. STONEY; HE, YUANZHENG
To: GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 018564/0100 →
Continuity (3)
Continuation In Part PCTUS200500639300 · Feb 25, 2005
Provisional Application 6054803900 · Feb 26, 2004
Related Publication 20070128627A1 · Jun 7, 2007